{
    "root": "045b8f7d-0fc2-4c65-a558-fe3e66f1845e",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "DILTIAZEM HYDROCHLORIDE in SODIUM CHLORIDE",
    "value": "20250228",
    "ingredients": [
        {
            "name": "DILTIAZEM HYDROCHLORIDE",
            "code": "OLH94387TE",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_645509"
        },
        {
            "name": "CITRIC ACID MONOHYDRATE",
            "code": "2968PHW8QP",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_31404"
        },
        {
            "name": "WATER",
            "code": "059QF0KO0R",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_15377"
        },
        {
            "name": "SODIUM HYDROXIDE",
            "code": "55X04QC32I",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32145"
        },
        {
            "name": "HYDROCHLORIC ACID",
            "code": "QTT17582CB",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_37527"
        },
        {
            "name": "SODIUM CHLORIDE",
            "code": "451W47IQ8X",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_26710"
        },
        {
            "name": "TRISODIUM CITRATE DIHYDRATE",
            "code": "B22547B95K"
        },
        {
            "name": "SORBITOL",
            "code": "506T60A25R",
            "drugbank_id": "https://go.drugbank.com/drugs/DB01638"
        },
        {
            "name": "NATURAL LATEX RUBBER",
            "code": "2LQ0UUW8IN"
        }
    ],
    "indications": {
        "text": "diltiazem hydrochloride sodium chloride injection non-dihydropyridine calcium-channel blocker indicated following : \u2022 temporary control rapid ventricular rate atrial fibrillation atrial flutter . ( 1.1 ) \u2022 rapid conversion paroxysmal supraventricular tachycardias ( psvt ) sinus rhythm . ( 1.2 )",
        "doid_entities": [
            {
                "text": "atrial fibrillation (DOID:0060224)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_0060224"
            }
        ],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "monitor ecg blood pressure . initial dose 0.25 mg/kg 20 mg intravenously 2 minutes . response inadequate 15 minutes , give one doses 0.35 mg/kg 25 mg intravenously 2 minutes . immediately following first bolus , begin intravenous infusion 5 mg/hour . increase 5 mg/hour 15 mg/hour needed tolerated . ( 2.1 , 2.2 , 2.3 ) mix drugs . ( 2.4 )",
        "doid_entities": [],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": "diltiazem hydrochloride sodium chloride injection supplied clear , colorless solution single-dose bag aluminum overwrap available : total strength per total volume strength per ml carton 10 single-dose bags ndc bag overwrap ndc 100 mg per 100 ml 1 mg/ml 44567-662-10 44567-662-01 250 mg per 250 ml 1 mg/ml 44567-663-10 44567-663-01 discard unused portion . store refrigeration 2\u00b0c 8\u00b0c ( 36\u00b0f 46\u00b0f ) . freeze . single-dose bags original overwraps may stored one month 20\u00b0c 25\u00b0c [ 68\u00b0f 77\u00b0f ] , [ usp controlled room temperature ] . bag port made natural rubber latex , pvc , dehp . product used within 28 days removal aluminum overwrap . manufactured : wg critical care , llc paramus , nj 07652 made switzerland",
    "adverseReactions": "diltiazem hydrochloride sodium chloride injection contraindicated following situations : \u2022patients sick sinus syndrome second- third-degree av block except presence functioning ventricular pacemaker . \u2022patients severe hypotension cardiogenic shock . \u2022patients demonstrated hypersensitivity . \u2022 concomitant iv beta-blockers . \u2022patients atrial fibrillation atrial flutter associated accessory bypass tract wpw syndrome . \u2022patients ventricular tachycardia .",
    "indications_original": "Diltiazem Hydrochloride in Sodium Chloride Injection is a non-dihydropyridine calcium-channel blocker indicated for the following: \u2022 Temporary control of rapid ventricular rate in atrial fibrillation or atrial flutter. ( 1.1) \u2022 Rapid conversion of paroxysmal supraventricular tachycardias (PSVT) to sinus rhythm. ( 1.2 )",
    "contraindications_original": "Monitor ECG and blood pressure. The initial dose is 0.25 mg/kg or 20 mg intravenously over 2 minutes. If response is inadequate at 15 minutes, give one or more doses of 0.35 mg/kg or 25 mg intravenously over 2 minutes. Immediately following first bolus administration, begin intravenous infusion at 5 mg/hour. Increase by 5 mg/hour up to 15 mg/hour as needed and tolerated. ( 2.1 , 2.2 , 2.3 ) Do not mix with other drugs. ( 2.4 )",
    "warningsAndPrecautions_original": "Diltiazem Hydrochloride in Sodium Chloride Injection is supplied as a clear, colorless solution in a single-dose bag with an aluminum overwrap available as:\n                  \n                     \n                     \n                     \n                     \n                     \n                        \n                           \n                              \n                                 Total Strength per Total Volume\n                              \n                           \n                           \n                              \n                                 Strength per mL\n                              \n                           \n                           \n                              \n                                 Carton of 10 single-dose bags NDC\n                              \n                           \n                           \n                              \n                                 Bag and Overwrap NDC\n                              \n                           \n                        \n                        \n                           \n                              100 mg per 100 mL\n                           \n                           \n                              1 mg/mL\n                           \n                           \n                              44567-662-10\n                           \n                           \n                              44567-662-01\n                           \n                        \n                        \n                           \n                              250 mg per 250 mL\n                           \n                           \n                              1 mg/mL\n                           \n                           \n                              44567-663-10\n                           \n                           \n                              44567-663-01\n                           \n                        \n                     \n                  \n                  Discard any unused portion.\n                  Store under refrigeration at 2\u00b0C to 8\u00b0C (36\u00b0F to 46\u00b0F). Do not freeze. The single-dose bags in their original overwraps may be stored for up to one month at 20\u00b0C to 25\u00b0C [68\u00b0F to 77\u00b0F], [See USP Controlled Room Temperature]. The bag and port are not made with natural rubber latex, PVC, or DEHP.\n                  Product should be used within 28 days of removal from aluminum overwrap.\n                  Manufactured for:\n                     WG Critical Care, LLC\n                     Paramus, NJ 07652\n                  Made in Switzerland",
    "adverseReactions_original": "Diltiazem Hydrochloride in Sodium Chloride Injection is contraindicated in the following situations: \n                  \n                     \n                        \u2022Patients with sick sinus syndrome or second- or third-degree AV block except in the presence of a functioning ventricular pacemaker. \n                     \n                        \u2022Patients with severe hypotension or cardiogenic shock. \n                     \n                        \u2022Patients who have demonstrated hypersensitivity to the drug.\n                     \n                        \u2022 Concomitant administration with IV beta-blockers.\n                     \n                        \u2022Patients with atrial fibrillation or atrial flutter associated with an accessory bypass tract such as in WPW syndrome.\n                     \n                        \u2022Patients with ventricular tachycardia.",
    "drug": [
        {
            "name": "DILTIAZEM HYDROCHLORIDE in SODIUM CHLORIDE",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_645509"
        }
    ]
}